I might have just found a niche peptide stock. $VKTX is the name. Here's the thesis: The fundamentals are crazy. < dual GLP-1/GIP agonist (subcutaneous + oral formulations) attacking the $100B+ obesity market < both Phase 3 VANQUISH-1 and VANQUISH-2 trials now fully enrolled

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin